
anatomy and extent of occlusive disease.
Detailed justiÔ¨Åcation
The atherosclerotic MAOD that leads to the development of CMI is a local manifestation of a systemic disease. Accordingly, patients undergoing treatment for
CMI have the typical cardiovascular risk factors and associated comorbidities (Table I). The associated comorbidities and risk factors should be managed optimally
before any revascularization for CMI, similar to patients
undergoing any major vascular surgical